Literature DB >> 25019071

OPN sesame.

Kung-Hao Liang1, Chau-Ting Yeh1.   

Abstract

Osteopontin (OPN) is a growth regulatory protein for hepatocellular carcinoma (HCC) and a potent chemoattractant for macrophages. Zhu and colleagues recently reported significant clinical associations between poor postoperative prognosis and the concurrent detection of tumoral OPN expression and peritumoral macrophage (PTM) infiltration. An in-depth understanding on the complex interaction between tumoral OPN and macrophage-infiltrated microenvironment opens new doors to novel anticancer treatments.

Entities:  

Keywords:  Metastasis; cancer recurrence; early detection; inflammation

Year:  2014        PMID: 25019071      PMCID: PMC4073313          DOI: 10.3978/j.issn.2304-3881.2014.02.09

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  15 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  A constitutive endogenous osteopontin production is important for macrophage function and differentiation.

Authors:  Tobias Nyström; Ponuts Dunér; Anna Hultgårdh-Nilsson
Journal:  Exp Cell Res       Date:  2007-01-12       Impact factor: 3.905

3.  The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.

Authors:  Hui Zhang; Qing-Hai Ye; Ning Ren; Lei Zhao; Yan-Fang Wang; Xin Wu; Hui-Chuan Sun; Lu Wang; Bo-Heng Zhang; Yin-Kun Liu; Zhao-You Tang; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-20       Impact factor: 4.553

4.  Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.

Authors:  Rong-Xin Chen; Yun-Hong Xia; Jie-Feng Cui; Tong-Chun Xue; Sheng-Long Ye
Journal:  J Gastroenterol Hepatol       Date:  2010-08       Impact factor: 4.029

Review 5.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.

Authors:  Toshimitsu Uede
Journal:  Pathol Int       Date:  2011-03-08       Impact factor: 2.534

6.  The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.

Authors:  Jian Sun; Hong-Mei Xu; Hai-Jun Zhou; Qiong-Zhu Dong; Yue Zhao; Li-Yun Fu; Zhen-Yu Hei; Qing-Hai Ye; Ning Ren; Hu-Liang Jia; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

7.  High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

Authors:  Tong Ding; Jing Xu; Fang Wang; Ming Shi; Ying Zhang; Sheng-Ping Li; Limin Zheng
Journal:  Hum Pathol       Date:  2008-11-07       Impact factor: 3.466

8.  A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo.

Authors:  Jianxin Dai; Bohua Li; Jinping Shi; Ling Peng; Dapeng Zhang; Weizhu Qian; Sheng Hou; Lei Zhao; Jie Gao; Zhiguo Cao; Jian Zhao; Hao Wang; Yajun Guo
Journal:  Cancer Immunol Immunother       Date:  2009-08-19       Impact factor: 6.968

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  1 in total

Review 1.  The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages.

Authors:  Yuying Tan; Lei Zhao; Yong-Guang Yang; Wentao Liu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.